Dr. Michael Edwad Gotthelf M.D.

Recommended Articles

• Muscular Dystrophy: Combining Brain-Computer Interfaces and Assistive Technologies

  With the development of modern computers and networks, assistive technologies (AT) for people with disabilities have changed a lot. Not only can one control the devices through the voice, indeed, most of the devices and appliances can be connected to the voice activation services. So one can change...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...

• Headache in the Back of the Head

  A headache experienced in the back of the head can have many different causes. Most of these causes can be identified by specific symptoms, such as the exact location of pain and the type or severity of pain experienced. In some cases, certain events can trigger these headaches.  CausesDoctors can...

• Judas Priest’s Glenn Tipton Diagnosed With Parkinson’s Disease

  Glenn Tipton, who is 70 years old and the infamous lead guitarist of Judas Priest, was diagnosed earlier this year with Parkinson’s disease. This diagnosis has prompted him to step down from the band's oncoming tour, because of how limited he would be in his performance.Glenn Tipton, born October...

• Multiple Sclerosis: How it Feels to Live with a Progressive Disease

  When spring kicks in, you might be hyper-aware now of everything you've done, good and bad, since last year at this time.  Maybe you're mulling over what you haven't achieved, or the weight you didn't lose that you promised as a New Years's resolution. Instead of being happy, you are sad with a...

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...